Hisako Yoshida

4.7k total citations
138 papers, 2.9k citations indexed

About

Hisako Yoshida is a scholar working on Nephrology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hisako Yoshida has authored 138 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Nephrology, 33 papers in Surgery and 22 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hisako Yoshida's work include Dialysis and Renal Disease Management (20 papers), Liver Disease Diagnosis and Treatment (12 papers) and Gout, Hyperuricemia, Uric Acid (11 papers). Hisako Yoshida is often cited by papers focused on Dialysis and Renal Disease Management (20 papers), Liver Disease Diagnosis and Treatment (12 papers) and Gout, Hyperuricemia, Uric Acid (11 papers). Hisako Yoshida collaborates with scholars based in Japan, United States and Netherlands. Hisako Yoshida's co-authors include Masao Omata, Yasushi Shiratori, Takeshi Kawabe, Kazuhiko Tsuruya, K. Ogura, Fumihiko Kanai, Naoya Kato, Tsuneo Ikenoue, Takanari Kitazono and Minoru Tada and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Applied Physics Letters.

In The Last Decade

Hisako Yoshida

133 papers receiving 2.8k citations

Peers

Hisako Yoshida
Fuad S. Shihab United States
Michael Fischereder Germany
Georges Mourad France
Paolo Rigotti Italy
Stephen J. Tomlanovich United States
Richard Borrows United Kingdom
Fritz Diekmann Spain
Marie Essig France
John J. Curtis United States
Éric Thervet France
Fuad S. Shihab United States
Hisako Yoshida
Citations per year, relative to Hisako Yoshida Hisako Yoshida (= 1×) peers Fuad S. Shihab

Countries citing papers authored by Hisako Yoshida

Since Specialization
Citations

This map shows the geographic impact of Hisako Yoshida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hisako Yoshida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hisako Yoshida more than expected).

Fields of papers citing papers by Hisako Yoshida

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hisako Yoshida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hisako Yoshida. The network helps show where Hisako Yoshida may publish in the future.

Co-authorship network of co-authors of Hisako Yoshida

This figure shows the co-authorship network connecting the top 25 collaborators of Hisako Yoshida. A scholar is included among the top collaborators of Hisako Yoshida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hisako Yoshida. Hisako Yoshida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Murasato, Yoshinobu, Hitoshi Nakashima, Hiroshi Sugino, et al.. (2025). Routine intracoronary imaging-guided left main coronary intervention. Scientific Reports. 15(1). 9504–9504.
2.
Imai, Takumi, Hiroki Namikawa, Koichi Yamada, et al.. (2024). Incidence and potential risk factors of human cytomegalovirus infection in patients with severe and critical coronavirus disease 2019. Journal of Infection and Chemotherapy. 31(1). 102452–102452. 2 indexed citations
3.
Saito, Yuichi, Atsushi Tanaka, Hisako Yoshida, et al.. (2024). Effects of Xanthine Oxidase Inhibition by Febuxostat on Lipid Profiles of Patients with Hyperuricemia: Insights from Randomized PRIZE Study. Nutrients. 16(14). 2324–2324. 3 indexed citations
4.
Tanaka, Atsushi, Hisako Yoshida, Ikuko Nakamura, et al.. (2024). Effect of the Xanthine Oxidase Inhibitor, Febuxostat, on WBC Count in Asymptomatic Hyperuricemia: Subanalysis of the Randomized PRIZE Study. Journal of Atherosclerosis and Thrombosis. 31(6). 864–875. 2 indexed citations
5.
Yoshida, Hisako, et al.. (2024). Real-world fracture risk, osteoporosis treatment status, and mortality of Japanese non-dialysis patients with chronic kidney disease stages G3–5. Clinical and Experimental Nephrology. 29(2). 236–247. 1 indexed citations
6.
Fujishima, Yuya, Hitoshi Nishizawa, Atsushi Tanaka, et al.. (2024). Effect of the Xanthine Oxidase Inhibitor Febuxostat on the Cardio-Ankle Vascular Index in Asymptomatic Patients with Hyperuricemia and Liver Dysfunction: A Sub-Analysis of the PRIZE Study. Journal of Atherosclerosis and Thrombosis. 32(4). 474–490. 2 indexed citations
7.
Kabata, Daijiro, et al.. (2024). Amino acids to prevent cardiac surgery-associated acute kidney injury: a randomized controlled trial. JA Clinical Reports. 10(1). 19–19. 12 indexed citations
8.
Hattori, Nobutaka, Y. Kawata, Takumi Imai, et al.. (2023). Survey on the Impact of the COVID-19 Pandemic on Patients with Parkinson’s Disease and Their Caregivers in Japan. Patient Preference and Adherence. Volume 17. 1221–1235. 1 indexed citations
9.
10.
Yamazaki, Takanori, Hisako Yoshida, Kotaro Matsumoto, et al.. (2023). Tissue responses to everolimus-eluting stents implanted in severely calcified lesions following atherectomy. Cardiovascular Intervention and Therapeutics. 39(1). 34–44. 4 indexed citations
11.
Tsuruya, Kazuhiko, Hisako Yoshida, Shunsuke Yamada, et al.. (2023). More rapid progression of brain atrophy in patients on peritoneal dialysis compared with hemodialysis: The VCOHP Study. Hypertension Research. 47(4). 887–897. 2 indexed citations
12.
13.
Yamada, Shunsuke, Hisako Yoshida, Masanori Tokumoto, et al.. (2022). Malnutrition-Inflammation Complex Syndrome and Bone Fractures and Cardiovascular Disease Events in Patients Undergoing Hemodialysis: The Q-Cohort Study. Kidney Medicine. 4(3). 100408–100408. 10 indexed citations
14.
Yamazaki, Takanori, Hisako Yoshida, Kazuhiro Nakao, et al.. (2021). Angioscopic Ulcerated Plaques in the Femoropopliteal Artery Associated with Impaired Infrapopliteal Runoff. Journal of Vascular and Interventional Radiology. 33(2). 97–103.e1. 1 indexed citations
15.
Ito, Kentaro, Shinya Sakata, Kohei Otsubo, et al.. (2021). MO4-5 A multicenter retrospective study of Oncomine Dx Target Test multi-CDx system for genetic profiling of NSCLC: WJOG13019L. Annals of Oncology. 32. S297–S297. 1 indexed citations
16.
Tanaka, Atsushi, Hisako Yoshida, Mamoru Nanasato, et al.. (2018). Sitagliptin on carotid intima-media thickness in type 2 diabetes patients receiving primary or secondary prevention of cardiovascular disease: A subgroup analysis of the PROLOGUE study. International Journal of Cardiology. 271. 331–335. 8 indexed citations
17.
Tsuruya, Kazuhiko & Hisako Yoshida. (2018). Brain Atrophy and Cognitive Impairment in Chronic Kidney Disease. Contributions to nephrology. 196. 27–36. 22 indexed citations
18.
19.
Maeda, Shingo, K. Ogura, Hisako Yoshida, et al.. (1998). Major virulence factors, VacA and CagA, are commonly positive in Helicobacter pylori isolates in Japan. Gut. 42(3). 338–343. 214 indexed citations
20.
Ogura, K., Fumihiko Kanai, Shin Maeda, et al.. (1997). High prevalence of cytotoxin positive Helicobacter pylori in patients unrelated to the presence of peptic ulcers in Japan. Gut. 41(4). 463–468. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fuad S. Shihab Breakdown of academic impact, for papers by Michael Fischereder Breakdown of academic impact, for papers by Georges Mourad Breakdown of academic impact, for papers by Paolo Rigotti Breakdown of academic impact, for papers by Stephen J. Tomlanovich Breakdown of academic impact, for papers by Richard Borrows Breakdown of academic impact, for papers by Fritz Diekmann Breakdown of academic impact, for papers by Marie Essig Breakdown of academic impact, for papers by John J. Curtis Breakdown of academic impact, for papers by Éric Thervet
Rankless by CCL
2026